GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Scorpius Holdings Inc.
Shares of Scorpius Holdings, a contract developer and manufacturer of biopharmaceuticals, reflect the demand for outsourcing in the biotech industry. Their price trajectory depends on the company's ability to attract clients and expand its production capacity.
Share prices of companies in the market segment - Pharma tests
Scorpius Holdings is a contract development and manufacturing organization (CDMO) that provides services to biopharmaceutical companies. We've classified it as a "Pharma Test." The chart below shows how investors view the pharmaceutical outsourcing sector.
Broad Market Index - GURU.Markets
Scorpius Holdings is a contract development and manufacturing organization (CDMO) that provides services to biopharmaceutical companies. As a significant player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Scorpius' performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
SCPX - Daily change in the company's share price Scorpius Holdings Inc.
For Scorpius Holdings, Inc., a contract manufacturing organization (CDMO), daily volatility reflects sensitivity to demand from biotech companies. This metric is an indicator of activity in the drug development sector.
Daily change in the price of a set of shares in a market segment - Pharma tests
Scorpius Holdings provides contract manufacturing services for biologics (CDMO). Its business depends on the health of the entire biotech industry and the volume of outsourcing. The chart below shows the volatility in this sector, helping to assess SCPX's performance.
Daily change in the price of a broad market stock, index - GURU.Markets
Scorpius Holdings is a contract manufacturer that helps other biotech companies produce their drugs. Its business serves as a barometer for the health of the entire biotech industry. Its stock price reflects investment in the sector and influences the overall market environment.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Scorpius Holdings Inc.
The year-over-year performance of Scorpius Holdings, which operates under the Nighthawk brand, tells the story of its transformation into a contract manufacturing organization (CDMO). Its 12-month market cap reflects its success in attracting customers to its production facilities after the failure of its own developments, a new bet for the future.
Annual dynamics of market capitalization of the market segment - Pharma tests
Scorpius, as a contract research organization (CRO), is betting on the growth of the biotech industry. Its performance relative to the sector will demonstrate the extent to which its services are in demand by pharmaceutical companies, making it a barometer for R&D activity in this important field.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Scorpius Holdings, a contract manufacturer for the pharmaceutical industry, is an "infrastructure" bet on biotech. Its performance relative to the market is a barometer of the health of the entire industry. The growth of the biotech sector leads to increased orders and allows the company to outpace the market without taking on the risks of clinical trials.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Scorpius Holdings Inc.
Scorpius (formerly Nighthawk) is a contract development and manufacturing organization (CDMO). Its business relies on R&D spending in the pharmaceutical industry. Its monthly price fluctuations reflect news of major manufacturing contracts.
Monthly dynamics of market capitalization of the market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing services for biopharmaceuticals, helping other biotech companies conduct research and bring their products to market. The chart below shows the overall dynamics of the pharmaceutical testing and services sector, which is an integral part of the biotech ecosystem.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Scorpius Holdings is a contract developer and manufacturer of biopharmaceuticals. Demand for its services depends on the level of funding in the biotech industry. Its shares may be sensitive to overall investor sentiment toward biotech, rather than the broader market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Scorpius Holdings Inc.
The weekly performance of Scorpius, a contract manufacturing organization, is a barometer for the biotech industry. Its stock price responds to demand from small biotech companies seeking manufacturing capacity for their experimental drugs.
Weekly dynamics of market capitalization of the market segment - Pharma tests
Scorpius Holdings (formerly Nighthawk Biosciences) provides contract development and manufacturing services for biopharmaceuticals. This chart compares its performance with the sector and helps understand how the market views its outsourcing business model for biotech companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Scorpius Holdings is a contract manufacturer for pharmaceutical companies. Its business is dependent on outsourcing trends in the pharmaceutical industry. The chart below helps us understand whether Scorpius's performance reflects general trends in the sector or whether its order book creates a unique profile.
Market capitalization of the company, segment and market as a whole
SCPX - Market capitalization of the company Scorpius Holdings Inc.
Scorpius's market capitalization tells the story of a contract manufacturing organization (CDMO) providing biopharmaceutical development and manufacturing services. Its dynamics reflect an attempt to build a business in a growing but competitive sector, where success depends on the ability to attract clients from the biotech industry.
SCPX - Share of the company's market capitalization Scorpius Holdings Inc. within the market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing services for biopharmaceuticals. Its small share of its segment's market capitalization reflects its role as a service company for the biotech industry. The chart below shows how its weight relates to total investment in pharmaceutical development.
Market capitalization of the market segment - Pharma tests
Scorpius Holdings is a contract research and manufacturing organization (CDMO) serving biotech companies. The chart below shows the market capitalization of this sector. Its growth reflects the trend toward outsourcing in the pharmaceutical industry, where Scorpius helps young companies develop their drugs.
Market capitalization of all companies included in a broad market index - GURU.Markets
Scorpius Holdings is a contract organization providing biopharmaceutical development and manufacturing services. Its market capitalization reflects the activity of the entire biotech industry. When Scorpius is busy, it means that many companies are pursuing promising developments, which is a good sign for the entire industry.
Book value capitalization of the company, segment and market as a whole
SCPX - Book value capitalization of the company Scorpius Holdings Inc.
Scorpius Holdings' book value is its equity and contract manufacturing operations (CDMOs), which provide development and production services for biological drugs to other pharmaceutical companies. This is the tangible, service-based foundation for the biotech industry. How has this asset changed? The chart below shows its dynamics.
SCPX - Share of the company's book capitalization Scorpius Holdings Inc. within the market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing services for biopharmaceuticals, owning laboratories and production facilities for this purpose. The chart shows the share of these tangible assets, reflecting its physical scale as a service company for the pharmaceutical industry.
Market segment balance sheet capitalization - Pharma tests
Scorpius, a contract manufacturer for the pharmaceutical industry, is a highly capital-intensive business. It requires the ownership of sterile production facilities. The BCap_Seg sector chart demonstrates how demanding and demanding this industry is.
Book value of all companies included in the broad market index - GURU.Markets
Scorpius's (formerly Nighthawk's) capital comes not from its own drugs, but from its CDMO manufacturing facilities, where it helps other biotech companies produce drugs for clinical trials. Its assets are its factory. The chart shows the physical weight of this contract manufacturer in the biotech ecosystem.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Scorpius Holdings Inc.
Scorpius Holdings provides contract development and manufacturing services for biopharmaceuticals. Its balance sheet includes laboratories and manufacturing facilities. Its market capitalization reflects the demand for outsourcing from biotech companies and the company's reputation as a reliable partner.
Market to book capitalization ratio in a market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing services for biopharmaceuticals, helping other biotech companies bring their products to market. Its valuation on the chart reflects the growing demand for outsourcing in the pharmaceutical industry.
Market to book capitalization ratio for the market as a whole
Scorpius Holdings, Inc. operates as a contract development and manufacturing organization for biopharmaceuticals. Its valuation is based on its production capacity and customer contracts. This chart helps understand how the market values biotech infrastructure companies against the backdrop of overall trends.
Debts of the company, segment and market as a whole
SCPX - Company debts Scorpius Holdings Inc.
Scorpius Holdings, a contract biomanufacturing organization (CDMO), uses capital to build and equip its facilities. This chart shows how the company is investing in creating infrastructure to manufacture complex biologics for other pharmaceutical companies, a capital-intensive but rapidly growing business.
Market segment debts - Pharma tests
Scorpius Holdings (formerly Nighthawk) is a contract manufacturing organization (CDMO) specializing in biologics. This business requires significant investment in certified manufacturing facilities. This chart shows how a small CDMO finances its capital-intensive assets to serve biotech clients.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Scorpius Holdings Inc.
Scorpius Holdings provides contract development and manufacturing services for biologics. This chart shows how the company uses debt to build and equip its laboratories and production facilities. It helps assess its financial strategy and risks in the competitive CDMO sector.
Market segment debt to market segment book capitalization - Pharma tests
Scorpius Holdings provides contract manufacturing (CDMO) services to biopharmaceutical companies, helping them produce complex biological drugs. This chart shows debt trends in the sector, helping to understand how Scorpius finances its capital-intensive manufacturing facilities and competes in the growing CDMO market.
Debt to book value of all companies in the market
Scorpius Holdings, Inc. (formerly Nighthawk Biosciences) provides contract development and manufacturing services for biologics, which requires investment in high-tech equipment. This chart shows the overall debt burden in the market, allowing one to assess how the company is using capital to expand its capacity to meet demand from the pharmaceutical industry.
P/E of the company, segment and market as a whole
P/E - Scorpius Holdings Inc.
Scorpius Holdings provides contract development and manufacturing (CDMO) services to biotech companies. This chart shows how the market values its manufacturing capacity. This trend reflects the growing demand for outsourcing from the pharmaceutical industry, particularly for the production of complex biologics.
P/E of the market segment - Pharma tests
Contract manufacturing for biotech, like Scorpius's, is a service business. This chart shows the average valuation for biopharmaceutical companies. It helps to understand that Scorpius is considered a "factory" for other biotech companies, and its success depends on the growth of the entire industry and its ability to attract customers to its manufacturing facilities.
P/E of the market as a whole
Scorpius Holdings (formerly Nighthawk) is a contract development and manufacturing organization (CDMO) that helps other pharmaceutical companies produce drugs. Its business depends on the volume of R&D in the pharmaceutical industry. This general sentiment graph influences biotech funding, but for Scorpius, the long-term trend toward manufacturing outsourcing is more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Scorpius Holdings Inc.
For Scorpius Holdings, Inc., a contract manufacturing company for biopharmaceutical companies, this chart illustrates market expectations for future orders. It reflects forecasts for the growth of biotech outsourcing and the company's ability to attract new clients.
%20P%2FE%20Scorpius%20Holdings%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Scorpius-Holdings-Inc.&v=1772668607024 "Chart of the company's future (projected) P/E Scorpius Holdings Inc.")
Future (projected) P/E of the market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing (CDMO) services for biologics to other biotech and pharmaceutical companies. The chart shows forecasts for the sector. This helps assess the market's perception of demand for outsourced manufacturing services in biotech and Scorpius's ability to attract and retain clients.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-tests&v=1772668607039 "Future (projected) P/E graph of the market segment - Pharma tests")
Future (projected) P/E of the market as a whole
Scorpius Holdings, Inc. (formerly Nighthawk Biosciences) is a contract development and manufacturing organization for biologics. It assists other biotech companies. Demand for its services depends on the overall R&D funding in the industry. This graph of overall risk appetite indirectly reflects how much money is flowing into biotech.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772668607057 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Scorpius Holdings Inc.
Scorpius Holdings provides contract development and manufacturing (CDMO) services to biopharmaceutical companies. Its revenue is based on the number of client projects. This chart illustrates how outsourcing in the pharmaceutical industry creates opportunities for companies with the necessary manufacturing capacity and expertise.
Profit of companies in the market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing services for biologics. This chart, which shows profitability in the pharmaceutical sector, demonstrates the importance of outsourcing for biotech companies. They help other companies, especially smaller ones, advance their drugs from concept to clinical trials by providing the necessary expertise and manufacturing capacity.
Overall market profit
Scorpius Holdings provides contract development and manufacturing services for biologics. The company helps other biotech firms bring their drugs from concept to production. Demand for its services depends on overall activity in the biotech sector. Economic growth, reflected in the graph, stimulates investment in biotech, increasing the number of Scorpius clients.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Scorpius Holdings Inc.
Scorpius Holdings provides contract development and manufacturing (CDMO) services to biotech and pharmaceutical companies, helping them produce biologics. This chart shows analysts' assessments of the growth of outsourcing in the pharmaceutical industry and the company's ability to attract new clients.
%20profit%20of%20the%20company%20Scorpius%20Holdings%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Scorpius-Holdings-Inc.&v=1772668607160 "Graph of future (projected) profit of the company Scorpius Holdings Inc.")
Future (predicted) profit of companies in the market segment - Pharma tests
Scorpius Holdings is a contract development and manufacturing organization (CDMO) providing services to biotech and pharmaceutical companies. Demand for its services depends on R&D activity in the pharmaceutical industry. This biotech chart reflects expectations for growth in outsourcing in drug development and manufacturing.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-tests&v=1772668607171 "Graph of future (predicted) profits of companies in a market segment - Pharma tests")
Future (predicted) profit of the market as a whole
Scorpius Holdings provides biopharmaceutical development and manufacturing services. Its clients include other biotech and pharmaceutical companies. This schedule, reflecting profit expectations, influences R&D funding in the industry, which directly determines demand for contract manufacturing services.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772668607192 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Scorpius Holdings Inc.
Scorpius Holdings is a contract development and manufacturing organization (CDMO) providing services to biotech companies. The chart shows how the market values its service revenue. It reflects the growing demand for outsourcing in the pharmaceutical industry and its ability to help other companies bring new drugs to market.
P/S market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing services for biologics to pharmaceutical companies. The company's revenue depends on the number and scale of client projects. This chart, which reflects the average valuation in the sector, helps understand how investors view this business model, which plays a vital role in the drug development ecosystem.
P/S of the market as a whole
Scorpius Holdings is a contract development and manufacturing organization (CDMO) that provides services to biotech and pharmaceutical companies. This chart, showing average market revenue estimates, helps understand how the market values the biotech "services" business, which benefits from overall industry growth.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Scorpius Holdings Inc.
Scorpius Holdings is a contract development and manufacturing organization (CDMO) that provides services to biopharmaceutical companies, helping them produce drugs for clinical trials. This chart shows how investors estimate future demand for outsourced manufacturing services, which depends on the level of funding in the biotech sector.
%20P%2FS%20Scorpius%20Holdings%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Scorpius-Holdings-Inc.&v=1772668607261 "The graph of the company's future (projected) P/S Scorpius Holdings Inc.")
Future (projected) P/S of the market segment - Pharma tests
Scorpius Holdings, Inc. is an integrated biomanufacturing company that provides contract development and manufacturing (CDMO) services to biotech and pharmaceutical companies. This chart shows the average estimated future sales in the biotech sector. It helps understand how the market views Scorpius's role in supporting drug development.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20tests&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-tests&v=1772668607274 "Future (projected) P/S market segment graph - Pharma tests")
Future (projected) P/S of the market as a whole
Scorpius Holdings provides contract development and manufacturing services for biological drugs to other pharmaceutical companies. This chart shows investor expectations for revenue growth. Demand for the company's services is an indicator of activity in the biotech industry. The more new drugs in development, the greater the demand for its capacity.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772668607326 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Scorpius Holdings Inc.
This chart shows the revenue of Scorpius Holdings, a contract manufacturing organization (CDMO) for the biopharmaceutical industry. Revenue is generated from providing biologic drug development and manufacturing services to other companies. The trend illustrates the demand for outsourcing in the biotech sector.
Sales of companies in the market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing services for biologics to pharmaceutical and biotech companies. This chart reflects the growth of outsourcing in the pharmaceutical industry. Scorpius is a valuable partner for many companies, helping them accelerate drug development without the need to build expensive in-house manufacturing facilities.
Overall market sales
Scorpius Holdings provides contract development and manufacturing services for biopharmaceuticals. Demand for its services depends on activity in the biotech sector. This total revenue chart reflects the state of the economy, which influences investment in R&D and drug manufacturing outsourcing.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Scorpius Holdings Inc.
Scorpius Holdings is a contract manufacturing organization (CDMO) providing biopharmaceutical development and manufacturing services to other pharmaceutical companies. Future revenues are dependent on outsourcing contracts. The chart shows the projected growth of the biopharmaceutical market.
%20sales%20of%20the%20company%20Scorpius%20Holdings%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Scorpius-Holdings-Inc.&v=1772668607389 "Schedule of future (projected) sales of the company Scorpius Holdings Inc.")
Future (projected) sales of companies in the market segment - Pharma tests
Scorpius Holdings is a contract development and manufacturing organization (CDMO) providing services to biotech and pharmaceutical companies, helping them produce biological drugs for clinical trials. This chart shows the forecast for the entire pharmaceutical services market, where manufacturing outsourcing is a key trend.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-tests&v=1772668607403 "Schedule of future (projected) sales of companies in the market segment - Pharma tests")
Future (projected) sales of the market as a whole
Scorpius Holdings provides contract development and manufacturing (CDMO) services to biotech and pharmaceutical companies. Demand for their services depends on the industry's R&D volumes. This chart, reflecting the investment climate in biopharma, is an indicator of how actively companies will outsource the development and manufacturing of their drug candidates.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772668607414 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Scorpius Holdings Inc.
Scorpius Holdings provides contract development and manufacturing services for biopharmaceuticals to pharmaceutical companies. Its profitability depends on the utilization of its production facilities and the number of client projects. This chart shows how the company, working behind the scenes in the pharmaceutical industry, builds a profitable business by helping others create medicines.
Market segment marginality - Pharma tests
Scorpius Holdings provides contract development and manufacturing (CDMO) services to biotech and pharmaceutical companies, specializing in large-molecule drugs. Profitability depends on their production capacity utilization and ability to secure long-term contracts. This chart shows their operating results as a service company.
Market marginality as a whole
Scorpius Holdings, formerly known as Nighthawk Biosciences, is a contract development and manufacturing organization (CDMO) that helps other biotech companies produce biological drugs for clinical trials. This overall profitability curve is important to them because it impacts biotech funding, which drives demand for their services.
Employees in the company, segment and market as a whole
Number of employees in the company Scorpius Holdings Inc.
Scorpius Holdings is a contract development and manufacturing organization (CDMO) serving biotech companies. Its staff consists of scientists and manufacturing specialists. Growth on this chart represents the expansion of its capacity and ability to serve more clients.
Share of the company's employees Scorpius Holdings Inc. within the market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing (CDMO) services to the biopharmaceutical industry. This chart reflects its manufacturing capacity. It shows the size of the team of scientists and technicians working at its facility, helping other companies, especially early-stage ones, produce materials for clinical trials.
Number of employees in the market segment - Pharma tests
Scorpius Holdings, Inc. is an integrated contract development and manufacturing organization (CDMO) providing services to biotech and pharmaceutical companies. This chart shows employment trends in the pharmaceutical outsourcing sector. The growth in the number of scientists and technicians reflects the high demand for development and manufacturing services for complex biological drugs.
Number of employees in the market as a whole
Scorpius Holdings is a contract organization providing biopharmaceutical development and manufacturing services. Its clients are biotech companies. Overall economic growth, visible in this chart, supports high levels of investment in biotech, ensuring a steady flow of orders for Scorpius from companies seeking outsourced manufacturing.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Scorpius Holdings Inc. (SCPX)
Scorpius Holdings (formerly Nighthawk Biosciences) is a contract development and manufacturing (CDMO) company for biopharmaceuticals. They help other biotech companies produce drugs for clinical trials. It's a service-based, yet high-tech, business. The chart shows the market value of their production capacity and research team. The high cost per employee reflects the technological complexity and marginality of their services.
%20of%20the%20company%20Scorpius%20Holdings%20Inc.%20(SCPX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Scorpius-Holdings-Inc.-SCPX&v=1772668607564 "Chart of market capitalization per employee (in thousands of dollars) of the company Scorpius Holdings Inc. (SCPX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma tests
Scorpius Holdings provides contract development and manufacturing services for biopharmaceuticals to pharmaceutical companies. It is a service business in the biotech industry. This chart shows how the market values its production capacity and scientific expertise, which enable it to serve other players in this capital-intensive industry.
%20by%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-tests&v=1772668607588 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma tests")
Market capitalization per employee (in thousands of dollars) for the overall market
Scorpius Holdings provides contract development and manufacturing services for biopharmaceuticals. The chart shows its valuation in the pharmaceutical outsourcing sector. It reflects how the team creates value by providing expertise and manufacturing capacity to other biotech companies, accelerating their development.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772668607639 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Scorpius Holdings Inc. (SCPX)
Scorpius Holdings is a contract development and manufacturing organization (CDMO). They don't develop their own drugs, but rather provide services (from process development to manufacturing) to other biotech companies. It's a B2B service business. This chart shows how efficiently their labs and factories are utilized through paid contracts.
%20Chart%20Scorpius%20Holdings%20Inc.%20(SCPX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Scorpius-Holdings-Inc.-SCPX&v=1772668607663 "Company Profit Per Employee (in thousands of dollars) Chart Scorpius Holdings Inc. (SCPX)")
Profit per employee (in thousands of dollars) in the market segment - Pharma tests
Scorpius Holdings is a contract development and manufacturing organization (CDMO) that helps other biopharmaceutical companies produce biological drugs for clinical trials. It's a service business. This metric reflects how cost-effectively they can manage their complex manufacturing processes.
%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-tests&v=1772668607669 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma tests")
Profit per employee (in thousands of dollars) for the market as a whole
Scorpius Holdings (SCPX) is a contract manufacturing organization (CDMO) for biopharmaceuticals (development and production). It's a B2B service. This chart shows how much their labs and factories (margin) are in demand by R&D companies and how efficiently they manage complex biotech processes.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772668607682 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Scorpius Holdings Inc. (SCPX)
Scorpius Holdings is a contract development and manufacturing organization (CDMO) providing services to biotech companies. This chart shows its manufacturing capacity utilization. The increase in revenue per employee indicates strong demand for its services in manufacturing complex biologics for clinical trials.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Scorpius-Holdings-Inc.-SCPX&v=1772668607698 "Sales chart per company employee Scorpius Holdings Inc. (SCPX)")
Sales per employee in the market segment - Pharma tests
Scorpius Holdings (SCPX) is a contract manufacturing organization (CDMO). They don't create their own drugs, but rather provide development and manufacturing services for complex biotech drugs to other pharmaceutical companies. This chart shows the revenue generated by each of their scientists and manufacturing technicians from these services.
Sales per employee for the market as a whole
Scorpius Holdings (SCPX) is a contract development and manufacturing (CDMO) company for biopharmaceuticals. It's a B2B service for biotech companies. The company helps others produce drugs for clinical trials. This chart shows how efficiently the company's staff of scientists and technicians generates service revenue by servicing contracts.
Short shares by company, segment and market as a whole
Shares shorted by company Scorpius Holdings Inc. (SCPX)
Scorpius Holdings is a contract manufacturing organization (CDMO) providing biotech drug development and manufacturing services. The bearish sentiment shown in this chart may be related to expectations of a slowdown in funding in the biotech sector, leading to a reduction in orders for CDMOs.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Scorpius-Holdings-Inc.-SCPX&v=1772668607744 "Short Shares Chart for the Company Scorpius Holdings Inc. (SCPX)")
Shares shorted by market segment - Pharma tests
This chart reflects sentiment in the contract manufacturing organization (CDMO) sector serving the pharmaceutical industry. Scorpius helps other companies develop and manufacture drugs. If investors are short this segment, they expect a slowdown in biotech R&D, a reduction in venture capital funding, and, consequently, a decline in outsourcing orders.
Shares shorted by the overall market
Scorpius is a contract manufacturer (CDMO) for biotech companies. Its clients are R&D companies. This chart illustrates the overall market pessimism. When investors are fearful, they stop funding small biotech companies. As a result, Scorpius' clients freeze R&D and reduce drug production orders.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Scorpius Holdings Inc. (SCPX)
Scorpius Holdings (SCPX) is a contract research organization (CRO) that helps biotech companies conduct preclinical trials and manufacture drugs. Their success depends on the overall R&D budgets of the pharmaceutical industry. This indicator tracks how investors view this order flow, indicating whether it's "overheated" (above 70) or "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Scorpius-Holdings-Inc.-SCPX&v=1772668607767 "RSI 14 indicator chart for the company's stock Scorpius Holdings Inc. (SCPX)")
RSI 14 Market Segment - Pharma tests
Scorpius Holdings (formerly Nighthawk) is a contract development and manufacturing organization (CDMO). They help other, mostly small, biotech companies manufacture their drugs (cell therapies, antibodies) for clinical trials. This chart reflects the overall sentiment in the CRO/CDMO sector and helps assess how the market views this industry.
RSI 14 for the overall market
Scorpius (SCPX) is a "supplier" for biotechs (contract manufacturing). This chart shows the "health" of its clients. In a euphoric mood, biotechs easily attract capital and actively pursue R&D, outsourcing production to SCPX. In a panic, R&D funding dries up, biotechs "freeze" research, and demand for services falls.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SCPX (Scorpius Holdings Inc.)
Scorpius Holdings (SCPX) is a contract manufacturing organization (CDMO), essentially a "factory for hire" for other biotech companies. They help produce complex biologics for clinical trials. This chart shows the average 12-month forecast from analysts, reflecting their view on Scorpius's ability to fill its capacity and win new contracts.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-SCPX-Scorpius-Holdings-Inc.&v=1772668607802 "A chart showing analyst consensus forecasts for the expected stock price. SCPX (Scorpius Holdings Inc.)")
The difference between the consensus estimate and the actual stock price SCPX (Scorpius Holdings Inc.)
Scorpius (SCPX) is a biotech "factory." The company is a boutique contract manufacturer (CDMO) that helps other R&D companies produce their drugs for clinical use. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their belief in the growth of R&D outsourcing.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-SCPX-Scorpius-Holdings-Inc.&v=1772668607803 "A chart showing the difference between the consensus forecast and the actual stock price. SCPX (Scorpius Holdings Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma tests
Scorpius Holdings (SCPX) is a contract manufacturer (CDMO) for biotech. The company helps other pharma startups produce their drugs for clinical trials. This chart shows analysts' overall expectations for the entire pharma testing (and R&D services) sector. It reflects whether experts believe in the growth of R&D outsourcing or anticipate a "winter" in biotech.
Analysts' consensus forecast for the overall market share price
Scorpius Holdings (SCPX) is a "hired factory" for biotech companies. They are a contract manufacturer (CDMO) that helps other, often small, pharmaceutical companies develop and manufacture their drugs. This chart shows the overall risk appetite. If analysts are bullish, biotech companies receive funding and then hire Scorpius to do the work.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Scorpius Holdings Inc.
Scorpius (formerly Nighthawk) operates in the biomanufacturing sector, providing services for the development and production of complex biotech drugs. It is a contract manufacturing organization (CDMO). This chart provides a comprehensive view of the company, assessing its ability to attract new projects, capacity utilization, and overall growth potential within the sector.
AKIMA Market Segment Index - Pharma tests
Scorpius Holdings (SCPX) isn't a tester, but a biotech factory. They're a contract manufacturer (CDMO) providing pharmaceutical testing and manufacturing services for complex drugs (antibodies, gene therapies) for other companies. This chart compares their service composite index to the sector, showing how their B2B model outperforms their competitors.
The AKIM Index for the overall market
Scorpius Holdings is a contract development and manufacturing organization (CDMO) for biopharmaceuticals. It's derived from NightHawk Biosciences. This chart, which reflects the market average, is a backdrop. It helps assess how SCPX, a biotech service business, compares to overall macroeconomic trends.
